AWH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AWH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Aspira Womens Health has the GF Score of 0, which implies that the company might have Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
1. Financial Strength : 0/10Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Aspira Womens Health might have Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Aspira Womens Health (NAS:AWH) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score | Performance Potential and All-in-One Screener Examples (1) |
91 - 100 | Highest outperformance potential |
81 - 90 | Good outperformance potential |
71 - 80 | Likely to have average performance |
51 - 70 | Poor future performance potential |
0 - 50 | Worst future performance potential, or not enough data |
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Thank you for viewing the detailed overview of Aspira Womens Health's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Nicole Sandford | director | 12117 BEE CAVES RD BLDG 3, STE 100, AUSTIN TX 78738 |
Minh Hoang Merchant | officer: General Counsel & Secretary | 1210 AVONDALE ROAD, HILLSBOROUGH CA 94010 |
Torsten Hombeck | officer: Chief Financial Officer | 529 W 42ND ST #6V, NEW YORK NY 10036 |
Celeste Rachelle Fralick | director | 2801 MESA ROAD, LUBBOCK TX 79403 |
Veronica Gh Jordan | director | C/O ALBANY MOLECULAR RESEARCH, INC., 26 CORPORATE CIRCLE, ALBANY NY 12212-5098 |
Stefanie L. Cavanaugh | director | 1120 S CAPITAL OF TX HWY, BLDG 1, STE 300, AUSTIN TX 78746 |
Ellen O'connor Vos | director | C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980 |
Jack W Schuler | 10 percent owner | 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045 |
Ryan Thinh Phan | officer: CSO & COO | 327 CARLTON AVE, LOS GATOS CA 95032 |
Jannie Prestridge Herchuk | director | 6331 LAVENDALE AVE, DALLAS TX 75230 |
Winfred Parnell | director | 6734 TALMADGE LANE, DALLAS TX 75230 |
Marlene Mclennan | officer: Interim Chief Financial Office | 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401 |
Ruby Sharma | director | 24 ARNOLD DRIVE, PRINCETON JCT. NJ 08550 |
Robert D Auerbach | director | C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588 |
Valerie Barber Palmieri | director, officer: President and CEO | 63 INDIAN LEDGE RD., MONROE CT 06468 |
From GuruFocus
By Marketwired • 10-15-2024
By GuruFocus News • 01-06-2025
By ACCESSWIRE • 02-11-2025
By Marketwired • 11-07-2024
By GuruFocus News • 02-15-2025
By Marketwired • 12-03-2024
By GuruFocus News • 10-07-2024
By GuruFocus Research • 08-13-2024
By GuruFocus News • 10-25-2024
By GuruFocus Research • 08-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.